Learn how the Hyperforma DynaDrive and S.U.B. and the Hyperforma 5:1 S.U.B. can be paired with the ExpiSf Expression System as scalable options for production of recombinant AAV for gene therapy. In this study, it was shown that the high titers obtained in the single-use bioreactors are comparable to those typically seen in glass reactors.

Complete this form to download the the application note "Production of AAV vector in HyPerforma S.U.B.s using the ExpiSf Expression System"

* Required field

*
*
*
*
*
*
*

What type of application best describes your work? (select all that apply)*

 Biosimilar
 Device/diagnostics
 Oligonucleotide therapy
 Vaccine
 Blood/plasma products
 Gene therapy
 Recombinant protein
 Other
 Cell therapy
 Monoclonal antibody
 Small molecule
*
 Contact me
 Request Quote, Demo or Sample
 No follow up
 

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.